Abstract: A pharmaceutical or medicinal preparation which comprises a mixture of the following five herbs: Boerhavia Diffusa, Picorrhiza Kurroa, Tephrosia Purpurea, Curcuma Longa and Trigonella Foenum-Graecum, or a mixture of the active ingredients that have been extracted from those herbs. The herbal formulation of the invention is effective for the treatment of hepatic and splenic disorders, thalassemias, Wilson's Disease, hematological malignancies, and as an adjuvant to cancer therapy.

Abstract: A pharmaceutical or medicinal preparation comprising a mixture of arsenic trioxide (As2O3) and the herbs Aloe Vera (Aloe Barbedensis), Withania Somnifera, Glycine Max, Rubia Cordifolia and Acacia Catechu, or a mixture of the active ingredients that have been extracted from those herbs. The herbo-mineral formulation of the invention is effective for the treatment of cancer, in particular refractory leukemias, lymphomas, myelodysplastic syndrome and aplastic anemias.

Abstract: A pharmaceutical or medicinal preparation which comprises a mixture of the following eleven herbs: Withania somnifera, Chlorphyton borivilianum, Boerhavia diffusa, Elephantopus scaber, Moringa oleifera, Tecoma undulata, Bauhinia purpurea, Ficus racemosa, Cyperus rotundus, Sphaeranthus acmella and Tinospora cordifolia; or a mixture of the active ingredients that have been extracted from those herbs or chemically synthesised. The herbal formulation of the invention is effective for the treatment of cancer, in particular squamous cell carcinomas, tumours and other metastatic states, including lung cancer.

Abstract: A pharmaceutical or medicinal preparation which comprises a mixture of the following seven herbs: Tinospora cordifolia, Aloa vera (Aloa barbedensis), Curcuma longa, Withania somnifera, Achyranthus aspera, Ocimum sanctum and Picorrhiza kurroa, or a mixture of the active ingredients that have been extracted from those herbs or chemically synthesised. The herbal formulation of the invention is effective for the treatment of cancer, in particular haematological malignancies.